Latest News about COVID/19 Vaccine
Recent news which mentions COVID/19 Vaccine
From Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
From Benzinga
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
March 29, 2022
From Benzinga
Pfizer, Moderna and J&J Face Shareholder Pressure To Make COVID-19 Shots More Available To Poorer Countries: WSJ
March 28, 2022
From Benzinga
From Benzinga
Biden Administration Contemplating Second COVID-19 Booster Shot Recommendation Within Weeks: Politico
March 23, 2022
From Benzinga
From Benzinga
From Benzinga
Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents
March 23, 2022
Tickers
NVAX
From Benzinga
From Benzinga
Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants
March 21, 2022
Tickers
SRNE
From Benzinga
Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters
March 18, 2022
From Benzinga
Like Pfizer, Moderna Seeks FDA Approval For Fourth COVID-19 Shot Or Second Booster Dose
March 18, 2022
From Benzinga
From Benzinga
Alnylam Hits Pfizer, Moderna With Patent Infringement Suits
March 17, 2022
From Benzinga
Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
March 17, 2022
From Benzinga
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows
March 14, 2022
From Benzinga
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate
March 10, 2022
Tickers
OGEN
From Benzinga
Novavax's COVID-19 Shot Inches Up To FDA Authorization: WSJ
March 07, 2022
Tickers
NVAX
From Benzinga
Johnson & Johnson's COVID-19 Vaccine Less Effective Against Hospitalization, French Study Shows
March 03, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
